- Home
- PMEC vs HOOK Comparison
PMEC vs HOOK Comparison
Compare PMEC & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- HOOK
- Stock Information
- Founded
- PMEC 1984
- HOOK 2011
- Country
- PMEC Singapore
- HOOK United States
- Employees
- PMEC N/A
- HOOK N/A
- Industry
- PMEC
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- PMEC
- HOOK Health Care
- Exchange
- PMEC Nasdaq
- HOOK Nasdaq
- Market Cap
- PMEC 26.1M
- HOOK 30.2M
- IPO Year
- PMEC 2023
- HOOK 2019
- Fundamental
- Price
- PMEC $0.75
- HOOK $2.00
- Analyst Decision
- PMEC
- HOOK Strong Buy
- Analyst Count
- PMEC 0
- HOOK 4
- Target Price
- PMEC N/A
- HOOK $34.50
- AVG Volume (30 Days)
- PMEC 71.5K
- HOOK 66.7K
- Earning Date
- PMEC 12-31-2024
- HOOK 11-14-2024
- Dividend Yield
- PMEC N/A
- HOOK N/A
- EPS Growth
- PMEC N/A
- HOOK N/A
- EPS
- PMEC N/A
- HOOK N/A
- Revenue
- PMEC $72,524,000.00
- HOOK $49,999,000.00
- Revenue This Year
- PMEC N/A
- HOOK $147.52
- Revenue Next Year
- PMEC N/A
- HOOK N/A
- P/E Ratio
- PMEC N/A
- HOOK N/A
- Revenue Growth
- PMEC 5.07
- HOOK 143.30
- 52 Week Low
- PMEC $0.49
- HOOK $1.88
- 52 Week High
- PMEC $4.15
- HOOK $11.30
- Technical
- Relative Strength Index (RSI)
- PMEC 50.76
- HOOK 26.63
- Support Level
- PMEC $0.65
- HOOK $2.01
- Resistance Level
- PMEC $0.79
- HOOK $2.27
- Average True Range (ATR)
- PMEC 0.07
- HOOK 0.18
- MACD
- PMEC -0.01
- HOOK 0.02
- Stochastic Oscillator
- PMEC 43.78
- HOOK 31.94
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.